NCT06405776 Effect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery
| NCT ID | NCT06405776 |
| Status | Recruiting |
| Phase | — |
| Sponsor | West China Hospital |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 276 participants |
| Start Date | 2023-06-05 |
| Primary Completion | 2024-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 276 participants in total. It began in 2023-06-05 with a primary completion date of 2024-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a further observation and follow-up of the patients enrolled in the registration number NCT05920980 to further evaluate the effect of long-term infusion of lidocaine on postoperative chronic pain, long-term quality of life and survival rate in patients undergoing colorectal cancer surgery.
Eligibility Criteria
Inclusion Criteria: 1. Participants were at least 60 years old; 2. American Society of Anesthesiologists (ASA) physical status I to III; 3. Body-mass index of 18-30 kg/m2; 4. Scheduled for elective colorectal surgery. Exclusion Criteria: 1. Metastases occurring in other distant organs; 2. Severe hepatic insufficiency (aspartate aminotransferase or alaninetransaminase or bilirubin \>2.5 times the upper limit of normal); 3. Renal impairment (creatinine clearance \<60 mL/min); 4. Cardiac rhythm disorders or systolic heart failure (second-and thirddegree heart block, ejection fraction \<50%); 5. Allergies to any of the trial drugs; chronic opioid use; 6. Inability to comprehend numeric rating scale.
Contact & Investigator
Chunling Jiang, PhD
STUDY DIRECTOR
West China Hospital
Frequently Asked Questions
Who can join the NCT06405776 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06405776 currently recruiting?
Yes, NCT06405776 is actively recruiting participants. Contact the research team at jiang_chunling@yahoo.com for enrollment information.
Where is the NCT06405776 trial being conducted?
This trial is being conducted at Sichuan, China.
Who is sponsoring the NCT06405776 clinical trial?
NCT06405776 is sponsored by West China Hospital. The principal investigator is Chunling Jiang, PhD at West China Hospital. The trial plans to enroll 276 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.